SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001171843-18-002576
Filing Date
2018-04-06
Accepted
2018-04-06 16:06:19
Documents
5
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a_040518.htm PRE 14A 970715
2 GRAPHIC logo.jpg GRAPHIC 6888
3 GRAPHIC cheung_sig.jpg GRAPHIC 2554
4 GRAPHIC proxycard_1.jpg GRAPHIC 275521
5 GRAPHIC proxycard_2.jpg GRAPHIC 161590
  Complete submission text file 0001171843-18-002576.txt   1587524
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14027 | Film No.: 18743269
SIC: 3841 Surgical & Medical Instruments & Apparatus